Company Analysis

Revelation Biosciences, Inc. (REVB)

Nasdaq: REVB · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 2020
Grade4.5
◀ Past 2.6● Present 3.7▶ Future 6.4
7 est.

Who runs Revelation Biosciences, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Rolke James
Chief Executive Officer. First filing Jan 2022, latest Aug 18, 2026, 0 filings in all.
Officers reporting now
2
of 5 people with a filing in the last fifteen months
Directors reporting now
3
15 people on the record since 2020
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Rolke JamesChief Executive OfficerJan 2022Aug 18, 2026none
Zygmont Chester Stanley IIIChief Financial OfficerJan 2022Aug 18, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Carver JenniferdirectorJan 2022Aug 18, 2026none
Chawla Lakhmir SdirectorOct 2023Aug 18, 2026none
Roper JessdirectorJan 2022Aug 18, 2026none
Earlier names on the record20, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton REVB · research, not advice